Cannabis in Greece
Medical OnlyOverview
Greece legalized medical cannabis in 2017 and subsequently established a framework for cannabis cultivation for medical and industrial purposes. The country's Mediterranean climate, similar to other successful cannabis cultivation regions, makes it attractive for large-scale production facilities. The Greek government has promoted cannabis cultivation as an economic development opportunity, particularly for agricultural regions.
The regulatory framework permits the cultivation of medical cannabis under license from the Greek government, with products intended primarily for export to other European markets. Several international cannabis companies have obtained Greek cultivation licenses, though the pace of actual facility development and production has been slower than initially anticipated due to bureaucratic delays and regulatory complexity.
Patient access to medical cannabis within Greece has been limited despite legalization. The domestic medical market is small, with relatively few physicians prescribing cannabis and limited product availability through pharmacies. The focus of Greece's cannabis industry has been primarily on cultivation for export rather than serving the domestic patient population.
Greece also decriminalized simple cannabis possession in 2017 by reducing penalties and introducing diversion programs as alternatives to criminal prosecution. This broader reform package, combined with the medical and cultivation frameworks, represented a significant shift in Greek cannabis policy, though recreational legalization remains off the political agenda.
Key Facts
- Medical cannabis and cultivation legalized in 2017
- Mediterranean climate favorable for large-scale cannabis cultivation
- Export-oriented cultivation industry with EU-GMP potential
- Limited domestic medical cannabis patient access
- Simple possession decriminalized with diversion programs
- Government promotes cannabis cultivation as economic development tool
Recent Developments
International cultivation license holders developing production facilities
Bureaucratic streamlining efforts to accelerate licensing process
Growing interest in cannabis tourism integration
Efforts to improve domestic patient access to medical cannabis
Investment Implications
Greece offers cannabis cultivation opportunities driven by its favorable climate and EU membership. Companies establishing EU-GMP production facilities in Greece can access the European medical market. However, regulatory and bureaucratic challenges have slowed development. The domestic market is small, so the investment thesis centers on export potential. Investors should evaluate whether Greek operations can achieve cost and quality advantages compared to Portuguese and Danish alternatives.